Locations:
Search
New system refines classification of cytogenetic abnormalities at time of response assessment and their clinical significance
New guidelines update recommendations
A podcast episode
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A podcast episode
Lifetime Achievement award-winner reflects on psychosocial support and caregiver readiness
Questions remain about the merits of asparaginase-based therapy
Radiation therapy produces anti-inflammatory response
Phase 1 study found mutant calreticulin-specific monoclonal antibody brings promising results with no dose-limiting toxicities
Two blood tests improve risk in assessment after ovarian ultrasound
Advertisement
Advertisement